You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 21, November 28, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (25)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Congestive Heart Failure/ Cardiomyopathy
 •Alert me on articles by topic

Subclinical Hypothyroidism and the Risk of Heart Failure, Other Cardiovascular Events, and Death

Nicolas Rodondi, MD, MAS; Anne B. Newman, MD, MPH; Eric Vittinghoff, PhD; Nathalie de Rekeneire, MD; Suzanne Satterfield, MD; Tamara B. Harris, MS, MD; Douglas C. Bauer, MD

Arch Intern Med. 2005;165:2460-2466.

Background  Subclinical hypothyroidism has been associated with systolic and diastolic cardiac dysfunction and an elevated cholesterol level, but data on cardiovascular outcomes and death are limited.

Methods  We studied 2730 men and women, aged 70 to 79 years, with baseline thyrotropin (TSH) measurements and 4-year follow-up data to determine whether subclinical hypothyroidism was associated with congestive heart failure (CHF), coronary heart disease, stroke, peripheral arterial disease, and cardiovascular-related and total mortality. After the exclusion of participants with abnormal thyroxine levels, subclinical hypothyroidism was defined as a TSH level of 4.5 mIU/L or greater, and was further classified according to TSH levels (4.5-6.9, 7.0-9.9, and ≥10.0 mIU/L).

Results  Subclinical hypothyroidism was present in 338 (12.4%) of the participants. Compared with euthyroid participants, CHF events occurred more frequently among those with a TSH level of 7.0 mIU/L or greater (35.0 vs 16.5 per 1000 person-years; P = .006), but not among those with TSH levels between 4.5 and 6.9 mIU/L. In multivariate analyses, the risk of CHF was higher among those with high TSH levels (TSH of 7.0-9.9 mIU/L: hazard ratio, 2.58 [95% confidence interval, 1.19-5.60]; and TSH of ≥10.0 mIU/L: hazard ratio, 3.26 [95% confidence interval, 1.37-7.77]). Among the 2555 participants without CHF at baseline, the hazard ratio for incident CHF events was 2.33 (95% confidence interval, 1.10-4.96; P = .03) in those with a TSH of 7.0 mIU/L or greater. Subclinical hypothyroidism was not associated with increased risk for coronary heart disease, stroke, peripheral arterial disease, or cardiovascular-related or total mortality.

Conclusions  Subclinical hypothyroidism is associated with an increased risk of CHF among older adults with a TSH level of 7.0 mIU/L or greater, but not with other cardiovascular events and mortality. Further investigation is warranted to assess whether subclinical hypothyroidism causes or worsens preexisting heart failure.


Author Affiliations: Department of Epidemiology and Biostatistics (Drs Rodondi, Vittinghoff, and Bauer) and Division of General Internal Medicine, Department of Medicine (Dr Bauer), University of California, San Francisco; Department of Community Medicine and Public Health, University of Lausanne, Lausanne, Switzerland (Dr Rodondi); Department of Medicine, University of Pittsburgh, Pittsburgh, Pa (Dr Newman); Laboratory of Epidemiology, Demography, and Biometry, National Institute on Aging, Bethesda, Md (Drs de Rekeneire and Harris); and Department of Preventive Medicine, University of Tennessee College of Medicine, Memphis (Dr Satterfield).


RELATED ARTICLES

Subclinical Hypothyroidism and Cardiovascular Disease
Lawrence M. Crapo
Arch Intern Med. 2005;165(21):2451-2452.
EXTRACT | FULL TEXT  

Subclinical Thyroid Dysfunction as a Risk Factor for Cardiovascular Disease
John P. Walsh, Alexandra P. Bremner, Max K. Bulsara, Peter O’Leary, Peter J. Leedman, Peter Feddema, and Valdo Michelangeli
Arch Intern Med. 2005;165(21):2467-2472.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Serum thyroid hormone levels may not accurately reflect thyroid tissue levels and cardiac function in mild hypothyroidism
Liu et al.
Am. J. Physiol. Heart Circ. Physiol. 2008;294:H2137-H2143.
ABSTRACT | FULL TEXT  

Thyrotropin Levels and Risk of Fatal Coronary Heart Disease: The HUNT Study
Asvold et al.
Arch Intern Med 2008;168:855-860.
ABSTRACT | FULL TEXT  

Thyroid Function and Lipid Subparticle Sizes in Patients with Short-Term Hypothyroidism and a Population-Based Cohort
Pearce et al.
J. Clin. Endocrinol. Metab. 2008;93:888-894.
ABSTRACT | FULL TEXT  

The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi and Cooper
Endocr. Rev. 2008;29:76-131.
ABSTRACT | FULL TEXT  

Upper Limit of Normal Serum Thyroid-Stimulating Hormone: A Moving and Now an Aging Target?
Fatourechi
J. Clin. Endocrinol. Metab. 2007;92:4560-4562.
FULL TEXT  

TRH Stimulation When Basal TSH is Within the Normal Range: Is There "Sub-Biochemical" Hypothyroidism?
Doi et al.
Clin Med Res 2007;5:145-148.
FULL TEXT  

Subclinical Thyroid Dysfunction and the Heart
Cappola
J. Clin. Endocrinol. Metab. 2007;92:3404-3405.
FULL TEXT  

Association Between Increased Mortality and Mild Thyroid Dysfunction in Cardiac Patients
Iervasi et al.
Arch Intern Med 2007;167:1526-1532.
ABSTRACT | FULL TEXT  

Serum Thyrotropin Measurements in the Community: Five-Year Follow-up in a Large Network of Primary Care Physicians
Meyerovitch et al.
Arch Intern Med 2007;167:1533-1538.
ABSTRACT | FULL TEXT  

The Association of Thyroid Dysfunction with All-Cause and Circulatory Mortality: Is There a Causal Relationship?
Volzke et al.
J. Clin. Endocrinol. Metab. 2007;92:2421-2429.
ABSTRACT | FULL TEXT  

Association Between Serum Free Thyroxine Concentration and Atrial Fibrillation
Gammage et al.
Arch Intern Med 2007;167:928-934.
ABSTRACT | FULL TEXT  

The Beneficial Effect of L-Thyroxine on Cardiovascular Risk Factors, Endothelial Function, and Quality of Life in Subclinical Hypothyroidism: Randomized, Crossover Trial
Razvi et al.
J. Clin. Endocrinol. Metab. 2007;92:1715-1723.
ABSTRACT | FULL TEXT  

The dominant negative thyroid hormone receptor beta-mutant {Delta}337T alters PPAR{alpha} signaling in heart
Buroker et al.
Am. J. Physiol. Endocrinol. Metab. 2007;292:E453-E460.
ABSTRACT | FULL TEXT  

Prevalence of Subclinical Thyroid Dysfunction and Its Relation to Socioeconomic Deprivation in the Elderly: A Community-Based Cross-Sectional Survey
Wilson et al.
J. Clin. Endocrinol. Metab. 2006;91:4809-4816.
ABSTRACT | FULL TEXT  

Interleukin-6 release from human abdominal adipose cells is regulated by thyroid-stimulating hormone: effect of adipocyte differentiation and anatomic depot
Antunes et al.
Am. J. Physiol. Endocrinol. Metab. 2006;290:E1140-E1144.
ABSTRACT | FULL TEXT  

Other articles noted
Evid. Based Med. 2006;11:63-64.
FULL TEXT  

Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults
Cappola et al.
JAMA 2006;295:1033-1041.
ABSTRACT | FULL TEXT  

Subclinical Hypothyroidism and Cardiovascular Disease
Journal Watch Cardiology 2006;2006:8-8.
FULL TEXT  

Subclinical Hypothyroidism and Cardiovascular Disease
JWatch General 2006;2006:1-1.
FULL TEXT  

Subclinical Hypothyroidism and Cardiovascular Disease
Crapo
Arch Intern Med 2005;165:2451-2452.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.